Alnylam Pharmaceuticals (ALNY) Current Deferred Tax Assets (2009 - 2010)

Alnylam Pharmaceuticals (ALNY) has 2 years of Current Deferred Tax Assets data on file, last reported at $1.9 million in Q3 2010.

• Quarterly Current Deferred Tax Assets changed N/A year-over-year to $1.9 million in Q3 2010, while the trailing twelve-month figure through Sep 2010 was $1.9 million (changed N/A YoY) and the FY2009 annual result came in at $1.9 million, changed N/A from the prior year.
• Current Deferred Tax Assets steadied at $1.9 million in Q3 2010, from $1.9 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $1.9 million in Q3 2010 to a low of $1.9 million in Q4 2009.